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Background: Astrocytes regulate neuronal function, synaptic formation andmaintenance partly through secreted
extracellular vesicles (EVs). In amyotrophic lateral sclerosis (ALS) astrocytes display a toxic phenotype that con-
tributes to motor neuron (MN) degeneration.
Methods:Weused human induced astrocytes (iAstrocytes) from 3ALS patients carrying C9orf72mutations and 3
non-affected donors to investigate the role of astrocyte-derived EVs (ADEVs) in ALS astrocyte toxicity. ADEVs
were isolated from iAstrocyte conditioned medium via ultracentrifugation and resuspended in fresh astrocyte
medium before testing ADEV impact on HB9-GFP+ mouse motor neurons (Hb9-GFP+ MN). We used post-
mortem brain and spinal cord tissue from 3 sporadic ALS and 3 non-ALS cases for PCR analysis.
Findings:We report that EV formation and miRNA cargo are dysregulated in C9ORF72-ALS iAstrocytes and this
affects neurite network maintenance and MN survival in vitro. In particular, we have identiﬁed downregulation
of miR-494-3p, a negative regulator of semaphorin 3A (SEMA3A) and other targets involved in axonal mainte-
nance. We show here that by restoring miR-494-3p levels through expression of an engineered miRNA mimic
we can downregulate Sema3A levels in MNs and increases MN survival in vitro. Consistently, we also report
lower levels of mir-494-3p in cortico-spinal tract tissue isolated from sporadic ALS donors, thus supporting the
pathological importance of this pathway in MNs and its therapeutic potential.
Interpretation: ALS ADEVs and their miRNA cargo are involved in MN death in ALS and we have identiﬁed miR-
494-3p as a potential therapeutic target.
Funding: Thierry Latran Fondation and Academy of Medical Sciences.
Crown Copyright © 2019 Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
Keywords:
Astrocytes
Neurodegeneration
Gene therapy
Axonal growth
Extracelular vesicles
miRNA
Amyotrophic lateral sclerosis
1. Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative dis-
ease characterized by motor neuron (MN) degeneration. The mecha-
nisms and sequence of events leading to MN death are still widely
unknown, but the observation that the ﬁrst pathophysiological changes
observed in patients involve neuromuscular junction (NMJ) disruption
have given rise to the theory known as the ‘dying-back’ hypothesis
[1]. Dysregulated RNA metabolism is strongly implicated in this patho-
genesis [2], as demonstrated by the many ALS-linked genes encoding
proteins involved in RNA metabolism, such as TARDBP and FUS [3]. In
particular, microRNA (miRNA) metabolism dysregulation has also
been implicated in ALS [4–6].
In addition, polymorphic (G4C2)n hexanucleotide repeat expan-
sions within the C9ORF72 gene are the most common genetic cause of
ALS and frontotemporal dementia [7,8]. They are known to mediate
neurotoxicity through multiple mechanisms including alterations of
pre-mRNA processing [9,10], along with dysregulations of autophagy,
protein homeostasis and vesicle trafﬁcking [11–13].
Although ALS is characterized by MN degeneration, rodent
studies have demonstrated that astrocytes dictate disease progres-
sion in vivo [14]and patient-derived astrocytes are toxic towards
wild-type MNs through both cell-to-cell contact and secreted fac-
tors in vitro [15–17]. While several hypotheses have been put for-
ward [18,19], there is no consensus on the nature of these toxic
factors.
Under normal physiological conditions, astrocytes regulate many
neuronal functions including axon maintenance [20], and at least part
of this communication is regulated through secreted extracellular vesi-
cles (EVs) [21,22]. Speciﬁcally, EV miRNA cargo can modulate neuronal
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and astrocytic function in health and disease [23,24]. In the context of
ALS, recent rodent-based studies have implicated cell-secreted miRNA
signaling in a number of pathogenic processes, from excitotoxicity
[24] to neuromuscular junction disruption [25].
Based on our previous research, we sought to determine whether
astrocyte-derived extracellular vesicles (ADEV) from ALS patients con-
tain distinct and/or altered levels of miRNAs that would account for
the astrocyte toxicity reported against MNs [16].
Here we show that astrocytes derived from C9ORF72-ALS pa-
tients have impaired EV formation. We also show that the miRNA
cargo of these EVs is speciﬁc to astrocytes compared to the ﬁbro-
blasts of origin and signiﬁcantly differs from healthy control astro-
cytes. Speciﬁcally, we have identiﬁed miR-494-3p as a key
regulator of Semaphorin 3A (Sema3A) and other molecules in-
volved in axonal maintenance, with dramatic consequences on ax-
onal/neurite length and motor neuron survival in vitro. Mir-494-3p
dysregulation was also detected in the cortico-spinal tract isolated
from post-mortem ALS biopsies, thus corroborating the importance
of this pathway in disease and supporting its validity for future
therapeutic development.
2. Materials and methods
2.1. Human sample ethics statement
All skin biopsy donors (Table 1) provided informed consent before
sample collection (University of Shefﬁeld, Study number STH16573, Re-
search Committee reference 12/YH/0330 or Coriell Institute).
2.2. Conversion of skin ﬁbroblasts to induced neural progenitor cells
(iNPCs)
Skinﬁbroblasts from3 controls and 3 C9-ALS patients (Table 1)were
reprogrammed as previously described [16]. Brieﬂy, 104 ﬁbroblasts
were grown in one well of a six-well plate. Day one post seeding the
cells were transduced with retroviral vectors containing Oct 3/4, Sox
2, Klf 4 and c-Myc. Following one day of recovery in ﬁbroblast medium,
DMEM (Gibco, Waltham, MA, USA) and 10% FBS (Life Science Produc-
tion, Bedford, UK) the cells were washed 1× with PBS and the culture
medium was changed to NPC conversion medium comprised of
DMEM/F12 (1:1) GlutaMax (Gibco, Waltham, MA, USA), 1% N2 (Gibco,
Waltham, MA, USA), 1% B27 (Gibco, Waltham, MA, USA), 20 ng/ml
FGF2 (Peprotech, Rocky Hill, NJ, USA), 20 ng/ml EGF (Peprotech, Rocky
Hill, NJ, USA) and 5 ng/ml heparin (Sigma, St. Louis, MO, USA). As the
cell morphology changes and cells develop a sphere-like form they
can be expanded into individual wells of a six-well plate. Once an
iNPC culture is established, the media is switched to NPC proliferation
media consisting of DMEM/F12 (1:1) GlutaMax, 1% N2, 1% B27, and
40 ng/ml FGF2.
2.3. iAstrocyte differentiation and maintenance
iAstrocytes were yielded as previously described [9,16]. Brieﬂy,
iNPCs were switched to astrocyte proliferation media, DMEM (Fisher
Scientiﬁc, Hampton, NH, USA), 10% FBS (Life science production, Bed-
ford, UK), 0.2% N2(Gibco, Waltham, MA, USA). Cells were grown in
10 cmdishes coatedwith ﬁbronectin for 7 days unless otherwise stated.
For Nanoparticle Tracking Analysis experiments, astrocyte medium
was switched to EV free medium (DMEM (Gibco, Waltham, MA, USA)
and 10% (v/v) knockout serum replacement (Gibco, Waltham, MA,
USA)) 24 h before medium collection (day 6 of differentiation). Pre-
conditioned media was collected from the iastrocytes at day 7 and cen-
trifuged at 300 ×g for 10 min, prior to evaluation using the ZetaView
(Particle Metrix, Meerbusch, Germany).
2.4. MN monocultures with EVs from iAstrocytes
Murine Hb9-GFP+ MN cultures were prepared from mouse embry-
onic stem cells (mESC) containing a GFP gene controlled by the
MN-speciﬁc promoterHb9 (kind gift fromThomas Jessel, Columbia Uni-
versity, New York). Hb9-GFP mESC were maintained by culturing on
primary mouse embryonic ﬁbroblasts (Merck, Burlington, MA, USA) in
mESC media (KnockOut DMEM (Gibco, Waltham, MA, USA), 15%
(v/v) embryonic stem-cell FBS (Gibco,Waltham,MA, USA), 2mM L-glu-
tamine (Gibco, Waltham, MA, USA), 1% (v/v) nonessential amino acids
(Gibco, Waltham, MA, USA) and 0.00072% (v/v) 2-mercaptoethanol
(Sigma, St. Louis, MO, USA)). mESCs were then differentiated into MN-
enriched cultures via embryoid bodies (EBs). Brieﬂy, mESCs were lifted
using trypsin, resuspended in EB medium (DMEM/F12 (Gibco,
Waltham, MA, USA), 10% (v/v) knockout serum replacement
(Gibco, Waltham, MA, USA), 1% N2 (Gibco, Waltham, MA, USA), 1 mM
L-glutamine (Gibco, Waltham, MA, USA), 0.5% (w/v) glucose (Sigma,
St. Louis, MO, USA) and 0.0016% (v/v) 2-mercaptoethanol (Sigma, St.
Louis, MO, USA)) and seeded into non-adherent Petri dishes. EB media
was replenished every day, and 2 μM retinoic acid (Sigma, St. Louis,
MO, USA) and 0.5 μM smoothened agonist (Sigma, St. Louis, MO, USA)
Research in context
Evidence before this study
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative dis-
ease characterized by motor neuron death, however, astrocytes
contribute to the neurodegenerative process. Recent studies
have demonstrated that astrocytes from ALS patients can induce
motor neuron death through secreted factors. Several studies
have focused on secreted proteins without identifying a culprit,
however.
Recent studies have highlighted the importance of microRNAs in
cell-to-cell communication and have implicated miRNAs in the
cross-talk between motor neurons and astrocytes in ALS.
Added value of this study
In this studywe tested the effect of extracellular vesicles (EVs) se-
creted by astrocytes from ALS patients as opposed to non-ALS
donors on motor neuron survival. We found that EVs secreted by
ALS astrocytes induce motor neuron death nearly at the same
levels as the conditioned medium. Moreover, we found that the
main component of EVs are miRNAs, molecules that negatively
regulate gene expression. Through a microarray study we identi-
fied several dysregulatedmiRNA that are likely to disrupt neuronal
function once taken up by motor neurons. In particular, we fo-
cused onmiR-494-3p that downregulates various genes including
semaphorin3A, which is involved in axonal growth and
maintenance.
Implications of all the available evidence
This study has uncovered the functional importance of EV secre-
tion dysregulation that had been previously described in
C9ORF72-ALS samples. Through the use of patient-derived astro-
cytes we have identified a number of new potential therapeutic
targets for ALS that can be manipulated to restore neuronal func-
tion and prevent motor neuron death. Although challenging to use
in gene therapy due to their ability to target several transcripts at
once, our study provides evidence that manipulation of individual
miRNAs can lead to significant beneficial downstream effects
in vitro to be validated in vivo.
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were added daily from day 2 to day 7 post-seeding to induce mESC dif-
ferentiation into MNs. After 7 days of differentiation, EBs were dissoci-
ated using 200 U/ml papain (Sigma, St. Louis, MO, USA). Hb9-GFP+
MN were sorted using FACS Aria machine and 40,000 cells/well were
plated in 96 well plates (Cellstar, Sigma, St. Louis, MO, USA) pre-
coated with laminin 1:200 (Sigma, St. Louis, MO, USA) and
polyornithine 1:1000 (Sigma, St. Louis, MO, USA) in PBS. MNswere cul-
tured in 100 μl of MN media (Knockout DMEM, F12 medium, 10%
Knockout Serum Replacement, 1 mM L-glutamine, 0.5% (w/v) glucose,
1% N2, 0.0016% (v/v) 2-mercaptoethanol, 20 ng/ml BDNF (Peprotech,
Rocky Hill, NJ, USA), 40 ng/ml CNTF (Peprotech, Rocky Hill, NJ, USA)
and 20 ng/ml GDNF (Peprotech, Rocky Hill, NJ, USA)) for 24 h before
treatmentwith either complete astrocyte conditionedmedia or isolated
extracellular vesicles (EVs) appropriately diluted in fresh iastrocyteme-
dium (DMEM (Gibco, Waltham, MA, USA), 10% FBS (Life Science Pro-
duction, Bedford, UK) and 0.2% N2(Gibco, Waltham, MA, USA)) in
order to keep the same concentration of EVs present in the conditioned
medium. Each treatment well, comprised one part MN media and two
parts either complete astrocyte conditioned media or isolated EVs or
isolated EVs diluted in complete MNmedium (including growth factors
BDNF/CNTF/GDNF at the concentrations speciﬁed above). MNs were
imaged using an INCELL analyser 2000 (GE Healthcare, Chicago, IL,
USA) 24 h after seeding (to conﬁrm the number of cells before treat-
ment), and then every 24 h onwards for 3 days. The number of viable
MN (deﬁned as GFP+ motor neuronal cell bodies with at least 1
axon) were analysed using the Columbus™ Data Storage and Analysis
System (RRID:SCR_007149; Perkin Elmer, Waltham, MA, USA). The
percentage MN survival was calculated as the number of viable motor
neurons at day 3 as a percentage of the number of viable MN at day 0
pre-treatment.
As for treatment withmiRNAmimics (MirVana, ThermoFisher,Wal-
tham,MA, USA), scramble and hsa-miR-494-3p, were added to the con-
ditioned medium or ADEVs on the day of treatment.
2.5. EV preparation
EVs were isolated from conditioned medium by ultracentrifugation
at 100,000 ×g for 90min at 4 °C using a 70ti rotor and Beckman Coulter
Ultracentrifuge after initial collection and centrifugation for 10min, 300
×g at room temperature and ﬁltration through a 0.22 μm ﬁlter to re-
move cell debris. The supernatant was then removed and the EV pellet
resuspended in 300 μl DEPC treated PBS.
2.6. NTA
Nanoparticle tracking analysis was conducted using the ZetaView
(RRID:SCR_016647; Particle Metrix, Meerbusch, Germany) and its re-
spective software (RRID:SCR_016647; ZetaView 8.03.08.03). Prior to
use the instrument was calibrated using polystyrene beads (100 nm).
Conditioned media samples taken from human induced astrocyte cul-
tures were loaded into the ZetaView cell. Nanoparticle tracking analysis
measurements were recorded at 11 different positions and three cycles
of readings were documented for each position. Following the with-
drawal of any outlier positions the ZetaView software calculated the
mean, median and mode sizes in addition to the concentration of parti-
cles within the sample.
2.7. EV transmitted electron microscopy
For immuno-gold EM, a 5 μl drop of resuspended EVs was deposited
onto the grid and adsorbed for 20 min. Grids were washed in 100 μl
drops of PBS 3 times, followed by blocking for 10 min in 100 μl of
blocking buffer consisting of 5% horse serum in PBS. A 5 μl drop of Ms.
CD63(TS63, Invitrogen; Cat# 10628D, RRID:AB_2532983; Carlsbad, CA,
USA) of 20 μg/ml was incubated on the grid for 20 min, washing the
grid in PBS 3 times at the end of incubation. 5 μl of anti-mouse IgG-
10 nm gold (Cat#ab39619; RRID:AB_954440; Abcam, Cambridge, UK)
in 5% horse serum was adsorbed onto the grid for 20 min, and washed
with PBS. The immunoreactionwas post-ﬁxedwith EMgrade 3% glutar-
aldehyde/formaldehyde for 5 min, and the sample was contrasted with
2% uranyl acetate for 60 s and washed 3 times with distilled water be-
fore drying overnight. Samples were imaged with a Fei Tecnai 2000
electron microscope at 80 kV.
2.8. RNA isolation and quantitative RT-PCR
RNA was harvested using the RNeasy Plus mini Qiagen kit (Qiagen,
Germantown, MD, USA) and total RNA was reverse transcribed using
the High Capacity cDNA Reverse Transcription kit (Applied Biosystems,
Foster City, CA, USA) in accordance with the manufacturer's instruc-
tions. Real-time quantitative PCR reactions were conducted using 2×
SYBR Green qPCR Master Mix (Low ROX) (Bimake, Houston, TX, USA)
and assayswere run on a StratageneMx3000P™ Real Time Thermal Cy-
cler (Agilent Technologies Ltd., Santa Clara, CA, USA). Mouse Sema3A
RNA levels were detected and relative quantiﬁcation calculated using
the 2−∆∆CT method. The following primers were utilised: mouse
Sema3A Fw 5’-TGTACTCTGGAACTGCTGCG-3′; Rv 5’-TCTCTGGGATG
AGATGGGCA-3′; mouse GAPDH Fw 5’-GCTACACTGAGGACCAGGTTG
TCT-3′; Rv 5’-AGCCCCGGCATCGAA-3′; human Sema3A Fw 5’–CACCAT
CACCCCATCAGGAC-3′; Rv 5’-CTCTGGGATGAGATGGGCAC-3′ and
human RPL13A Fw 5’-CAAGCGGATGAACACCAACC-3′; Rv 5’-TTTTGT
GGGGCAGCATACCT-3′.
For TaqMan qPCR 6 genes associated with EV formation were se-
lected (Table 2) and PCR was performed using PrimeTime qPCR 5′ nu-
clease assays (IDT technologies, Coralville, IA, USA) as described
above. Gene expression values were determined using the ddCt calcula-
tion following normalization toβ-Actin expression, also evaluated using
the associated PrimeTime qPCR 5′ nuclease assay.
For miRNA analysis, total RNA was isolated using TRIzol™ Reagent
(Invitrogen, Carlsbad, CA, USA) as per the manufacturer's guidelines
TaqMan Small RNA Assay (20×) for hsa-miR-103 and hsa-miR-494-3p
and TaqMan Universal PCR Master Mix II (2×) (both Life Technologies
Ltd., Carlsbad, CA, USA) were used for real-time quantitative PCR reac-
tions and the assays were conducted on a Stratagene Mx3000P™ Real
Time Thermal Cycler (Agilent Technologies Ltd., Santa Clara, CA, USA).
2.9. Microarray analysis
Total RNA was extracted from EV pellets derived from the condi-
tionedmedia of C9ORF72 patient and control patient induced astrocytes
using the Direct-Zol RNAmini-prep (ZymoResearch, Irvine, CA, USA) as
per the manufacturer's instructions. RNA was labelled using the
Table 1
Details of ﬁbroblast donors.
Cell line Diagnosis Mutation Age at collection (y) Gender Source Identiﬁer
AG08620 Non-ALS ̶ 64 Female Coriell Institute RRID:CVCL_4L17
155 Non-ALS ̶ 42 Male UoS RRID:CVCL_UF81
3050 Non-ALS ̶ 55 Male UoS RRID: CVCL_UH66
78 fALS C9ORF72 68 Male UoS RRID:CVCL_UF84
183 fALS C9ORF72 51 Male UoS RRID:CVCL_UF85
201 fALS C9ORF72 66 Female UoS RRID:CVCL_UF86
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FlashTag biotin HSR RNA labelling kit (Affymetrix, Santa Clara, CA, USA)
according to the manufacturer's instructions. Brieﬂy, 2 μl of RNA Spike
Control Oligos were added to 8 μl of RNA, whilst ATP mix was diluted
1:500 in 1 mM Tris. 5 μl of Master Mix was added to 10 μl RNA/Spike
Control Oligos and incubated at 37 °C heat for 15 min (Poly (A)-tailing
reaction). To the Poly (A)-tailed RNA 4 μl of 5× FlashTag Biotin HSR Li-
gation Mix and 2 μl of T4 DNA Ligase was added and following a
30 min incubation at room temperature the reaction was stopped by
adding 2.5 μl of HSR Stop Solution.
Labelled RNA fromeach samplewas thenprepared for hybridisation.
The hybridisation cocktail, comprised of 110.5 μl of Hybridization Mas-
ter Mix and 21.5 μl of biotin-labelled sample was incubated at 99 °C
for 5min and then 45 °C for 5min. The samplemixturewas then loaded
into an array and placed into a hybridization oven and incubated at 48
°C and 60 rpm for 16 to 18 h. Arrays were then washed and stained
using Stain Cocktails 1/2 and scanned with the Affymetrix GeneChip
Scanner 3000.
Affymetrix Expression Console was used to evaluate the
hybridisation efﬁcacy and probe set expression of the GeneChip
miRNA Array 4.0. Differential miRNA expression between samples
were analysed using Affymetrix Transcriptome Analysis Console for
RNA species annotated within the human genome. The Affymetrix Ex-
pression Console was then used to evaluate probe set expression after
normalization using the detected above background (DABG) method.
DABG is a detection metric where the intensity from each perfect
match probe is compared to a distribution of background probes and
provides a probability that value of the signal intensity if part of the
background noise [26]. Different normalization methods and cutoffs
are used in miRNA expression analysis depending on the expression
level of the miRNAs in the sample analysed [27,28]. After normalization
and after applying a pvalue cutoff ≤0.05, differentially expressed
miRNAs were evaluated after applying fold changes ≥2, 1.5 and 1.2.
Due to the low number of miRNA displaying a fold change ≥2, fold-
change of 1.5 and 1.2 were used as an arbitrary threshold to perform
pathway enrichment analysis in order to identify the pathways that
are overall affected by ALS ADEVs.
To elucidate pathways targeted by dysregulated miRNAs three on-
line analytical tools were used, Database for Annotation, Visualization
and Integrated Discovery (DAVID) [29], DIANA-mirPath [30] and
miRSystem [31]. MiRSystem generates a list of enriched pathways that
are regulated by queried miRNAs by incorporating miRNA expression
values and matching miRNAs with the latest annotation [31]. It com-
bines seven different algorithms and two validated databases to identify
target genes and uses ﬁve pathway databases to characterize the
enriched pathways. DIANA-miRPath performsmiRNA pathway analysis
and allows queried miRNAs and target genes to be visualized on path-
way maps [30]. DAVID is a widely cited and used tool that discovers
enriched functional-related gene groups and allows them to be visual-
ized on pathway maps [29]. DAVID and DIANA-miRPath utilize enrich-
ment p-values while miRSystem uses ranking scores based on the
afﬁnity of the interactions between miRNAs and target genes [31].
Five pathways that were common to more than two tools were found.
From the ﬁve common pathways listed for up and downregulated
miRNAs, two pathways that were of our interest were selected and
genes that are involved in those pathways were found. The most
enriched miRNAs were found by selecting genes, involved in the path-
ways of interest that were commonly found between the analytic tools.
2.10. Post mortem tissue
Autopsy donations to the Shefﬁeld Brain Tissue Bank were per-
formedwith the written consent of the next of kin for the use of tissues
for scientiﬁc research. Slices of brain and segments of spinal cord were
frozen on copper plates in liquid nitrogen vapour and stored at−80 °C.
Six samples were retrieved from deep freezing (Table 3), and sam-
ples of motor cortex, spinal cord and lateral corticospinal tract taken
by a qualiﬁed neuropathologist.
The remaining nervous system tissue was formalin ﬁxed for diag-
nostic conﬁrmation and characterisation. The Shefﬁeld Brain Tissue
Bank Management Board gave ethical approval for use of tissue in this
study under the provision to act as a Research Tissue Bank as approved
by the Scotland Research Ethics Committee (ref. 08/MRE00/103).
2.11. Statistical analysis
All statistical testswere conductedusingGraphPadPrism7 software
(RRID:SCR_002798). Statistical analysis was performed by either
Student's t-test, one-way ANOVA with Tukey post-hoc analysis, or
two-way ANOVA with Sidak post-hoc analysis, depending on the num-
ber of variables in the respective experiment. All experimentswere per-
formed a minimum of three times. p b .05 was considered statistically
signiﬁcant. All p values and n values are documented in the ﬁgure
legends.
3. Results
3.1. Conditionedmedium and extracellular vesicles fromC9orf72 astrocytes
are toxic to MNs
We previously showed that C9orf72 iAstrocytes derived through di-
rect conversion of ﬁbroblasts into iNPCs induced a decrease in survival
in Hb9-GFP+mouseMNs in co-culture compared to non-ALS astrocytes
[16]. Herewe tested the effect of iAstrocyte conditionedmediumonMN
monocultures, to determine if secreted factors are main players in C9-
Table 2
Primers and probes for TaqMan qPCR.
Primer
name
Primer sequence
(5′ – N3′)
Probe sequence
(5′ – N3′)
ALIX-F GAAGCACAGGTGGT
GGAG
56FAM/CATGGTTCT/ZEN/TGGCGCTGGAG
TTG
ALIX-R CAGCAGGAGGACAT
GCAC
TSG101-F TTTTCCAGAGCAGAAC
TGAGT
56FAM/AACCTCGGC/ZEN/TACTTCTTGATCTA
AACGG
TSG101-R GAAAAAGGGTCACC
AGAAACTG
CHMP2B-F TCGTCATCAGAACCGT
CAAAG
56FAM/CAGAAGGAA/ZEN/AACATGAAAAT
GGAAATGACTGAAGA
CHMP2B-R AGGCAGTTAACAAG
AAGATGGA
CHMP4B-F GGAACATTTGGTAG
AGGGACTG
56FAM/TGGCGGAAT/ZEN/TAGAAGAACTA
GAACAGGAGG
CHMP4B-R AGGGTTTGGAGAAG
AGTTTGAC
VPS4A-F CTCTTGCCCAAAGTCC
TCTG
56FAM/TTCTTCACT/ZEN/TTCAGGAGGTCGTC
TGC
VPS4A-R TCTTAGAGCCTGTGGT
TTGC
β-Actin-F CCAGTGGTACGGCC
AGA
56FAM/CCATGTACG/ZEN/TTGCTATCCAGGCT
GT
β-Actin-R GCGAGAAGATGACC
CAGAT
Table 3
Details of post-mortem tissue donors, including gender, age, post-mortem delay (PMD)
and diagnosis.
Case ID Gender Age PMD Diagnosis
C1 F 63 31 h Carcinoid Tumor
C2 M 63 25 h Mesolthelioma
C3 M 67 63 h Hepatocellular carcinoma
sALS1 M 66 40 h sALS
sALS2 F 63 36 h sALS
sALS3 M 66 19 h sALS
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ALS astrocytic-mediated neurotoxicity as previously reported for other
genetic subtypes [15,17].
Consistent with previous data, C9-ALS astrocyte conditioned me-
dium treatment of MN monocultures resulted in 50–75% increased
MN death compared to controls after 72 h (Fig. 1a, b, e; p b .0001
(Two-way ANOVA)). Since extracellular vesicles (EVs) have been impli-
cated in cell-to-cell communication in a number of neurodegenerative
diseases [32], we decided to determine their role in astrocyte-
mediatedMN death in C9-ALS. We isolated EVs from C9 iAstrocyte con-
ditioned medium (10 ml) via ultracentrifugation, resuspended them in
fresh non-conditioned astrocyte medium (10 ml) or complete MN me-
dium with growth factors (10 ml) and we then treated the MN mono-
cultures. Our data reveal that C9-EVs are equally toxic as the astrocyte
conditioned medium (Fig. 1c-e, p b .0001 (Two-way ANOVA)). Dilution
of the EVs in complete MN medium containing BDNF, GDNF and CNTF
still resulted in MN death, proving that EVs are toxic to MNs (Supple-
mentary Fig. 1). We also report here that ADEVs isolated from control
astrocytes are consistently, even if not statistically signiﬁcant, less sup-
portive compared to whole conditioned medium (Fig. 1e) while C9-
EVs are consistently less toxic than whole conditioned medium. This
suggests that other factors not packaged into ADEVs contribute to MN
health/death. Consistent with these ﬁndings, MN medium alone is not
as supportive as astrocyte-conditioned medium from non-ALS controls
(Fig. 1e and Supplementary Fig. 2a, b), proving that astrocytes have an
active role in supporting neurite growth and synaptic formation.
3.2. EV biogenesis is impaired in C9orf72 astrocytes
Having assessed the detrimental effect of EVs secreted by C9-ALS as-
trocytes, we sought to characterize their abundance in the conditioned
medium. We used the ZetaView Nanoparticle Tracking Analysis (NTA)
system to identify particle size and number in conditioned medium
from3 controls and 3 C9-ALS patients. Quantiﬁcation revealed nodiffer-
ence in the overall size range of EVs secreted by controls or patients,
typically rangingbetween 70 and 200 nm.Most particles range between
50 and 120 nm, with a clear peak at 100 nm, indicating that exosomes
are the main component of the total EV pool (Fig. 2a). We conﬁrmed
ADEV isolation by transmitted electron microscopy (TEM) and
immunogold staining for CD63 (Fig. 2b and c).
Interestingly, ADEV quantiﬁcation showed that iAstrocytes from C9
patients secrete fewer vesicles than healthy individuals across a range
of vesicle sizes (Fig. 2d and Fig. 3). It was recently reported that
C9orf72 not only is involved in autophagy [13], but also in vesicle traf-
ﬁcking [11]. For this reason, we decided to assess the mRNA expression
level of proteins involved in EV formation and processing. Consistent
with the observed reduction in EV secretion, qRTPCR analysis showed
that transcripts encoding for C9orf72, TSG101, CHMP4B and VSP4A are
signiﬁcantly downregulated in C9-ALS iAstrocytes (Fig. 2e).
3.3.MicroRNAs regulating axonal maintenance are selectively dysregulated
in C9 patient ADEVs
Recent studies have provided strong evidence that astrocytes can
regulate neuronal health through EV-secreted miRNAs and indeed we
found that between 30 and 80% of the iAstrocyte EV RNA cargo is com-
posed of miRNAs (Supplementary Table 1). Therefore, we proceeded to
interrogate the panel of miRNAs secreted via ADEVs by 3 control and 3
C9-ALS iAstrocyte lines using AffymetrixmiRNA Microarray Chips.
The miRNA expression levels were determined using Expression
Console (Affymetrix) and the number of miRNAs detected above back-
ground (DABG) was 6632. Hierarchical clustering and principal compo-
nent analysis (PCA) of the detected miRNAs clearly identiﬁed patients
and controls as two separate groups (Fig. 3a, b). We interrogated the
data for differentially expressed transcripts by setting a threshold with
p-value ≤.05 and fold change ≥1.5 we identiﬁed 64 dysregulated
miRNAs (51 upregulated and 13 downregulated). We then applied a
less stringent fold-change ≥1.2 to ensure consistencywithin our results,
as one would expect that the pathways identiﬁed with more stringent
criteria would still be present when the criteria are relaxed to allow
performing a broader pathway enrichment analysis. This less stringent
analysis identiﬁed 193 differentially expressed miRNAs, 116 were up-
regulated whilst 77 were downregulated (Supplementary Table 2).
In order to identify transcripts that are targeted by dysregulated
miRNAs, two different web-based analytic tools, DIANAmiRPath and
miRSystemwere used, as they are based on different algorithms andda-
tabases [30,31]. To interrogate the enriched pathways targeted by the
dysregulated miRNAs, we then used miRSystem and DAVID, which
use different ranking systems. Pathway identiﬁcation and ranking
through different algorithms gave us conﬁdence that common hits
would be statistically robust. Of the top 5 pathways identiﬁed by these
two tools, axonal guidance and maintenance as well as adherens junc-
tions were identiﬁed through both approaches and regardless of the
fold change cutoff applied (Supplementary Table 3).
To identify which pathways might be dysregulated in multiple cell
types affected by the C9 mutation, versus pathways that are astrocyte-
speciﬁc, hence potentially involved in MN death, we interrogated the
miRNA proﬁle of EVs secreted by C9-ALS ﬁbroblasts compared to unaf-
fected controls through the same workﬂow. The PCA identiﬁed 4
Fig. 1. Conditioned medium (CM) and extracellular vesicles (EVs) from C9-ALS iAstrocytes induceMN death. Representative images of Hb9-GFP+MNmonocultures treated for 72 h with
astrocyte conditionedmedium from control (CTR) or C9-ALS (C9) astrocytes (a and b respectively) or EVs isolated from the same conditionedmedia (c and d respectively). Quantiﬁcation
ofHB9-GFP+MNswith axons performed after 3 days of treatment reveals that conditionedmedium (solid bars) and EV treatment (checked bars) have similar effects onMNmonocultures
(e), with C9-ALS astrocytemediumand EVs inducing signiﬁcantly lowerMNsurvival. Survival ofMNmonocultures inMNmedium (black solid bar) used as comparative reference (n=3).
Two-way ANOVA (p b .0001), 3xControls versus 3xC9-ALS, N= 3 per condition, error bar = SD. Scale bar = 20 μm.
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groups, clearly separating the miRNA proﬁle of ﬁbroblasts from
iAstrocytes and control and patients within each group (Fig. 3b). We
found that, while dysregulation of adherens junctions is a category pres-
ent in both data sets, axonal guidance andmaintenance is unique to the
iAstrocytes with 13 dysregulated miRNAs involved in the pathway
(Fig. 3c). Through pathway analysis, we identiﬁed hsa-miR-494-3p as
an upstream target in regulating axonal maintenance, with its primary
target being Semaphorin 3A (Sema3A). Increased Sema3A expression
has been recently described in post mortem motor cortex of sporadic
ALS patients [33]. MiR-494-3p was also the most dysregulated miRNA
identiﬁed in the axonal maintenance pathway (microarray data: fc =
−2.38, p= .047 (One-way ANOVA)) and its downregulation was vali-
dated via TaqMan qPCR (Fig. 3d).
3.4. MiR-494-3p mimic restores SEMA3A levels and increases MN survival
In order to test the effect of miR-494-3p on its identiﬁed target, i.e.
motor neuronal Sema3A, we treated HB9-GFP+ mouse MN monocul-
tures with conditioned medium from control or C9-ALS iAstrocytes
supplemented with either a scramble miRNA (miR-scr) or a miR-
494-3p mimic and then we evaluated the expression level of
Sema3A via qRT-PCR. Mouse HB9-GFP+ MNs could be used because
miR-494-3p is highly conserved between mouse and human. The re-
sults show that treatment with C9 conditioned medium indeed signif-
icantly increased the levels of Sema3A mRNA in HB9-GFP+ MN by 46%
after only 48 h of treatment (Fig. 4a). Indeed, treatment of the MNs
with a miR-494-3p mimic in the presence of C9 iAstrocyte condi-
tioned medium signiﬁcantly reduced the levels of Sema3A by 25% in
the MNs (Fig. 4a).
We then assessed the functional effect of this transcriptional
regulation to verify the link between miR-494-3p downregulation
and astrocyte-mediated MN death. We cultured HB9-GFP+ mouse
MNs and we treated them with conditioned medium from controls
or C9 patients supplemented with either a miR-scr or miR-494-3p
mimic. We then measured MN number (Fig. 4b), neurite length
(Fig. 4c) and number of nodes/intersections (Fig. 4d) to assess not
only MN survival over time, but also branching and neurite tree com-
plexity, which is expected to be directly affected by Sema3A
expression.
As expected MNs treated with C9 conditioned medium displayed
signiﬁcantly lower MN survival, neurite length and number of nodes
per cell (Fig. 4b-d) compared to controls, however, miR-494-3p
treatment led to a complete rescue in neurite length and number
of nodes per cell (Fig. 4c, d), accompanied by a signiﬁcant 20–25%
increase in MN survival compared to miR-scr treated cells
(Fig. 4b). Comparable results were obtained when MN monocul-
tures were treated with ADEVs isolated from the iAstrocyte-
conditioned medium and then resuspended in fresh non-
conditioned medium supplemented with either miR-scr or miR-
494-3p (data not shown).
In order to evaluate the relevance of our in vitro data in human dis-
ease, we assessed the expression levels of miR-494-3p and SEMA3A in
the motor cortex and lateral cortico-spinal tract of the spinal cord in
post-mortem tissues from sALS patients. We detected signiﬁcantly
lower levels of miR-494-3p (p = .02, Two-tailed t-test), while
SEMA3A did not show a signiﬁcant increase as predicted in the
cortico-spinal tract when comparing 3 sporadic ALS (sALS) patients to
3 non-ALS controls (Fig. 4e, f).
Fig. 2. EV biogenesis is impaired in C9-ALS iAstrocytes. Representative size distribution graph (a) of ADEVs and TEM (b, c-i, c-ii) show that most ADEVs range between 50 and 120 nm.
ADEVs are positive for CD63 (arrow heads) with immunogold labeling (c-iii). ADEV direct quantiﬁcation using the ZetaView Nanoparticle Tracking System (d) shows a signiﬁcant
decrease in the number of particles secreted by C9 iAstrocytes (One-way ANOVA; p b .01). This suggests impairment in vesicle formation, as supported by TaqMan qRT-PCR data
showing downregulation in a number of transcripts involved in EV biogenesis in C9 iAstrocytes (e). t-test (**p b .01; *** p b .001), 3xControls versus 3xC9-ALS, N = 3 per condition,
error bar = SD.
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4. Discussion
Neurodegenerative disorders are extremely complex diseases char-
acterized by high heterogeneity and interplay between different cell
types. Discoveries of the past 20 years have highlighted that ALS is
part of a disease spectrum ranging from frontotemporal dementia
(FTD) to pure motor neurone disease, it is multifactorial in origin, with
contribution of genetic, epigenetic and environmental factors and it un-
ravels through a yet undeciphered communication between neuronal
and non-neuronal cells [34,35]. Astrocytes have multiple functions,
from maintaining tissue homeostasis to supporting neurite growth
and remodeling during development as well as maintenance during
adulthood (reviewed by Clarke and Barres, 2013) [36].
Although massive progress has been made in understanding the
chemical signals that regulate the motor neuron-astrocyte crosstalk,
very little is known about the role of micro RNAs (miRNAs) in this
communication.
Work carried out by us and others has shown that astrocytes are
major players in ALS pathology, (reviewed by Ferraiuolo, 2014) [37].
In particular, it has been shown that astrocytes derived from either
post-mortem tissues or ﬁbroblasts from ALS patients are toxic to MNs
and this toxicity is also transferred through conditioned medium
[16,17].
ADEV cargo has been interrogated before as a culprit not only for
motor neurone injury, but also disease spreading, as mutant SOD1 was
detected in the exosomes secreted by primary astrocytes overexpress-
ing the mutant SOD1 gene [38].
Several recent studies, however, have turned their attention towards
EV miRNA, rather than protein, cargo. Most of these studies have been
performed in rodent models overexpressing mutant SOD1 and have
identiﬁed motor neuron-secreted miRNAs regulating astrocytic func-
tion [24].
On the contrary, in the present study, we focused on astrocytes and
on understanding how secretedADEVsmight contribute toMNdegener-
ation. We report that induced astrocytes (iAstrocytes) derived from
human ﬁbroblasts secrete less EVs than unaffected controls, consistent
with recent data collected in C9orf72 knockdown cell models and iPSC-
derived neurons from patients [11]. This characteristic seems to be spe-
ciﬁc to the role of C9orf72, as primary mouse astrocytes expressing mu-
tant SOD1 were reported to secrete more exosomes than controls [38].
Of great relevance for the EVs ﬁeld, we also observed that EV secre-
tion decreases with cell density in vitro, thus highlighting the impor-
tance of monitoring cell growth parameters and keeping them
consistent across conditions.
Our data show that ADEVs isolated from iAstrocyte conditionedme-
dium are sufﬁcient to cause MN death even in presence of trophic fac-
tors, thus demonstrating that ADEVs carry toxic factors.
Moreover, our miRNA proﬁling shows ADEVs from ALS patients and
unaffected controls carry a unique miRNA cargo distinct from the ﬁbro-
blasts of origin, which are, in fact, not toxic to MNs. Interestingly for as-
trocytes that have not been primed withmotor neurons, our data show
that iAstrocytes secrete miRNAs regulating a number of transcripts
encoding proteins involved in axonal growth and maintenance, simi-
larly to primary astrocytes [23]. This indicates that this regulatory pro-
gram of miRNA expression is intrinsic to this cell type and altered in
C9ORF72-ALS.
Consistentwith this observation, HB9-GFP+wild-typemousemotor
neurons treated with motor neuron medium display shorter neurites
Fig. 3.MicroRNAs regulating axonal maintenance are selectively dysregulated in C9 ADEVs. MiRNAs secreted by C9 and Control (CTR) iAstrocytes identify two separate groups in the
hierarchical clustering analysis (a). The PCA plot (b) shows how EV-secreted miRNAs differentiate iAstrocytes (iA) and ﬁbroblasts (Fib) on one axis and controls (CTR) and C9 patients
(C9) on another axis. iA also show more dramatic differences between patients and controls compared to ﬁbroblasts. Pathway analysis of the dysregulated miRNAs identiﬁes axonal
growth and maintenance as the most affected pathway (c). Downregulated (in blue) miRNAs target Semaphorins, RhoA and Rock, thus predicting an increase in these proteins, which
would lead to growth cone collapse. Upregulated miRNAs (in red) target Ephs and Wwp1, which would lead to their downregulation. Wwp1 inactivates NogoA, thus this would also
lead to axonal collapse. TaqMan qRT-PCR conﬁrms signiﬁcant downregulation of miR-494-3p, which negatively regulates Sema3A (d). N = 3 per group; error bar = SD. Two-tail
unpaired t-test (p b .05). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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and less complex projection network than motor neurons treated with
conditioned medium from unaffected controls (Supplementary Fig. 2).
Additionally, conditioned medium from C9-ALS astrocytes causes axo-
nal shortening before motor neuron cell body loss.
Our study has identiﬁed several miRNAs involved in regulating axo-
nal/neurite maintenance and growth, in particular, we have identiﬁed
signiﬁcant downregulation ofmiR-494-3p, amiRNA involved in the reg-
ulation of several genes, including SEMA3A. Our data demonstrate that
astrocyte-secreted miR-494-3p manipulation is effective in regulating
SEMA3A neuronal levels in vitro and that its upregulation through an
engineered miRNA mimic rescues both neurite length and network
complexity, as well as motor neuron survival.
Recent studies have also shown that Sema3A increase in ALS is not
limited to the periphery [39], but it is also a central phenomenon affect-
ingmotor neurons in themotor cortex of sporadic ALS patients [33], as-
trocytes in cases of spinal cord injury [40] and oligodendrocytes in
multiple sclerosis [41].
Elegant studies, however, have highlighted the complex role of
SEMA3A in axonal development, positioning and maintenance [20] in
CNS and have reported that under normal conditions speciﬁcally
astrocyte-secreted SEMA3A has a pro-survival role on spinal MN rather
than detrimental, while the opposite is true for cortical neurons [42]. In
our study, however, we have not investigated the levels of SEMA3A se-
creted by astrocytes and its role on MN survival.
Fig. 4.MiR-494-3p mimic restores SEMA3A levels and increases MN survival. QRT-PCR results show that HB9-GFP+ MNs treated with C9 iAstrocyte conditioned medium supplemented
with a scramble miRNA (miR-scr) display elevated levels of Sema3A compared to control iAstrocyte conditioned medium treatment + miR-scr (a). Sema3A levels, however, are
downregulated after 48 h treatment with a miR-494-3p mimic (a). N = 3 per condition; Error bars = SD. Decrease in Sema3A corresponds with improvement in MN survival (b),
increase in neurite length (c) and number of nodes/intersection in MN monocultures (d) treated with C9 iAstrocyte conditioned medium plus miR-494-3p. MN measurements were
performed 72 h post-treatment. In b N = 3 per condition; in c and d 3 N = 9 (independent replicates for each of the 3 patients and 3 controls); error bar = SD. Statistical analysis:
Two-way ANOVA with multiple comparison test and Sidak correction (*p b .05; **p b .01; ***p b .001; ****p b .0001). QRT-PCR analysis of lateral cortico-spinal tract tissue from 3 non-
ALS and 3 sporadic ALS patients with limb onset showed a signiﬁcant 30% reduction in miR-494-3p (e) (two-tailed t-test, p = .02), while no signiﬁcant change was detected in
SEMA3A (f) (two-tailed t-test p= .08).
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Our in vitro data indicate that intrinsic high levels of SEMA3A inMNs
are associated with neurite retraction and MN death and exogenous
miR-494-3p is able to decrease Sema3A levels. The MN rescue observed
in cultures treated with C9-ALS ADEV supplemented with miR-494-3p,
however, is likely to be the result of the action of miR-494-3p on several
targets acting upon axonal maintenance and MN survival rather than
solely regulation on motor neuronal semaphorin (Fig. 5).
Neuronal degeneration and synaptic loss are phenomena affecting
both the CNS as well as the NMJ and they can be identiﬁed in clinic at
diagnosis. Because not all the synapses are affected or lost at the same
time, their preservation is an appealing intervention even after symp-
tom onset.
In our in vitro system, unfortunately, we were not able to test the ef-
fect of miR-494-3p selectively on the axon as opposed to the neurite
tree, which would have clariﬁed whether the crosstalk happening cen-
trally in the motor cortex and spinal cord has an effect also on the pe-
riphery, i.e. the NMJ. It is likely that the stimuli applied by the
astrocytes in the brain and spinal cord on the MN cell bodies have a
deep impact on the axons and the distal neuronal cell compartment. Fu-
ture in vitro experiments should utilize microﬂuidic chambers, where
the two cell compartments can be kept separated and the effect of
ADEVs can be tested onto neurites or axons separately.
Using post-mortem tissue from sALS patients, we show here that
within the cortico-spinal tract, the motor pathway formed by the de-
scending axons of the primary cortical MNs in themotor cortex towards
the lowerMNs in the brainstem and spinal cord, we have detected a de-
crease in miR-494-3p. These data support the potential role of this
miRNA not only in the context of C9-ALS pathology, but the wider
sALS population.
The lack of speciﬁcity that characterizes miRNAs might pose a limi-
tation in terms of safety concerns for in vivo manipulation, however,
engineered miRNAsmight satisfy the need to target multiple molecules
in the same or different pathways at the same time. Gene therapy ap-
proaches targeting single genes have been proven safe and efﬁcacious
in the ﬁeld of neuromuscular disorders [44,45], supporting the idea
that targeted and timed genemanipulation could be developed as a po-
tential therapeutic approach.
This study is of great relevance not only for the ﬁeld of ALS, but po-
tentially other neurodegenerative conditions, where miR-494-3p ex-
pression might be used to preserve neurite/axonal health.
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